John Wilson

Overview

Gender
male

Wilson is Managing Director of ViraCyte, LLC, and the CEO of Wilson Wolf Manufacturing. Mr. Wilson has over 30 years of experience in the design, development and manufacture of products for the field of biotechnology, including cell culture devices and bioreactors. Mr. Wilson has obtained over 50 related patents with numerous patents currently pending. He is the co-inventor of the G-Rex® platform, which has revolutionized T cell manufacturing practices with its simple, reliable and scalable cell production. Mr. Wilson is also the co-inventor of the CELLineTM product line. Prior to co-founding Wilson Wolf Manufacturing and ViraCyte, Mr. Wilson was a principal mechanical engineer at Cellex Biosciences (now The Cell Culture Company) where he contributed to the world’s first commercially available fully-automated hollow fiber bioreactor cell culture system. Mr. Wilson has a BA in Business Administration and a BA in Economics from Hamline University in Minnesota and a B.S. in Mechanical Engineering from the University of Minnesota.

Jobs

Number of Current Jobs
1
John Wilson has 1 current jobs including CEO & Co-Founder at Marker Therapeutics , .
Organization Name Title At Company Start Date End Date
Marker Therapeutics CEO & Co-Founder Jan 1, 2015 Detail